FDA — authorised 31 July 1944
- Marketing authorisation holder: ABBVIE
- Status: approved
FDA authorised Dicuman on 31 July 1944
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 31 July 1944.
ABBVIE holds the US marketing authorisation.